PRP injections typically last 6 to 12 months for most applications, though results vary significantly depending on what’s being treated, your age, and other individual factors. The effects aren’t permanent for any condition, so maintenance treatments are part of the long-term plan.
When Results Start and How Long They Last
After a PRP injection, most people begin noticing improvement within 4 to 6 weeks. That’s the window when concentrated platelets are releasing growth factors that stimulate tissue repair, collagen production, and stem cell activity. You won’t feel better overnight, and some initial soreness at the injection site is normal during the first week or two.
The peak benefit usually arrives a few months after the injection or after completing an initial series. From there, the timeline depends heavily on what you’re treating.
Knee Osteoarthritis: 6 to 12 Months
For knee osteoarthritis, the most studied PRP application, patients commonly report 6 to 12 months of pain relief. Mayo Clinic physicians describe a 60% to 70% chance of success, defining success as at least a 50% improvement in pain and function lasting 6 to 12 months. That’s a meaningful improvement, but it also means roughly a third of patients don’t respond well enough to consider the treatment a success.
PRP tends to outperform hyaluronic acid injections over time. One study found that the re-intervention rate at 24 months was significantly lower for PRP patients (22.6%) compared to hyaluronic acid patients (37.1%). PRP also showed clinically significant functional improvement for at least one year, while hyaluronic acid benefits tend to fade sooner.
Tendon Injuries: Potentially Years
Chronic tendon problems may be where PRP shines brightest in terms of longevity. A large study on Achilles tendinopathy followed patients for an average of about four years (range of 2 to 8 years) after a single PRP injection. Function scores improved dramatically, jumping from a baseline of 45 to 88 out of 100, and 91.6% of treated tendons were rated as having satisfactory outcomes at final follow-up. Only 8.4% needed a second injection.
This makes sense biologically. Tendons heal slowly because of limited blood supply, and PRP delivers a concentrated dose of growth factors directly to the damaged tissue. Once a tendon genuinely repairs, the benefit can persist far longer than it does for degenerative joint conditions like osteoarthritis, where ongoing wear continues to break down cartilage.
Hair Loss: Up to 12 Months Per Cycle
For hair restoration, PRP results last up to 12 months, but the treatment requires an initial series rather than a single injection. Most protocols call for three sessions spaced about a month apart, followed by maintenance treatments every 6 to 12 months. PRP stimulates hair follicles and can increase hair density, but it’s not a permanent fix. Once you stop treatment, the benefits gradually fade.
How well PRP works for hair loss depends partly on the severity of your condition and your individual platelet concentration. People with early-stage thinning tend to respond better than those with advanced hair loss.
Skin Rejuvenation: About 6 Months
PRP facials (sometimes called “vampire facials”) produce measurable improvements in skin texture, pore size, wrinkle depth, and collagen density. A review in Skin Research and Technology found that a series of three PRP injections led to significant skin renewal at six months, confirmed by both objective measurements and patient self-assessments. Patient satisfaction scores averaged above 90% at the six-month mark. Collagen fiber density increased substantially on the treated side compared to pre-treatment levels.
Like hair treatments, skin rejuvenation with PRP requires periodic maintenance to sustain results. Most people schedule follow-up sessions every 6 to 12 months.
Factors That Shorten or Extend Your Results
Not everyone gets the same mileage from PRP, and the research has identified several variables that make a real difference.
Age is the biggest one. PRP is made from your own blood, so the quality of your platelets matters. Lab studies have shown that PRP from younger donors produces significantly more cartilage-building proteins and better tissue repair than PRP from older donors. In one study, PRP from aged donors showed no improvement in cartilage health at all, while PRP from young donors induced genuine regeneration. A German expert panel found that younger patients with less severe disease consistently had better outcomes.
Body weight also plays a role. Higher body fat is correlated with worse PRP outcomes for joint conditions, likely because excess weight accelerates cartilage breakdown and because adiposity independently affects cartilage health through inflammatory pathways, not just mechanical stress.
Sex matters too. Men tend to have higher concentrations of key growth factors and cytokines in their PRP compared to women. Older women face a compounded disadvantage: higher osteoarthritis risk combined with potentially less potent PRP.
Severity of the condition is perhaps the most intuitive factor. Early-stage osteoarthritis responds better than advanced disease. Mild hair thinning responds better than extensive loss. The less damage PRP has to work against, the longer and more effectively it works.
What a Typical Treatment Schedule Looks Like
For joint conditions, many providers start with a single injection and reassess at 6 to 12 months. If the first injection works well, you can repeat it when symptoms return. Some providers recommend a series of two or three injections spaced a few weeks apart for more severe cases.
For hair loss and skin rejuvenation, the standard approach is three initial sessions spaced about four weeks apart, followed by maintenance every 6 to 12 months. This front-loading is designed to build up a cumulative effect before switching to periodic touch-ups.
The type of PRP preparation can also vary. Some formulations include white blood cells (leukocyte-rich) while others filter them out (leukocyte-poor). Research hasn’t definitively proven one lasts longer than the other across all conditions. The choice often depends on what’s being treated and the provider’s clinical judgment.